Related references
Note: Only part of the references are listed.Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure
Andrew M. Siedlecki et al.
KIDNEY INTERNATIONAL (2009)
A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats
Maarten P. Koeners et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Severe left ventricular systolic dysfunction may reverse with renal transplantation: Uremic cardiomyopathy and cardiorenal syndrome
R. Zolty et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats
Luis Michea et al.
HYPERTENSION (2008)
Cardiorenal Syndrome
Claudio Ronco et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Systolic dysfunction portends increased mortality among those waiting for renal transplant
Angelo M. de Mattos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy
Attila J. Szabo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Nitric oxide deficiency in chronic kidney disease
Chris Baylis
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Cardiomyocytes as effectors of nitric oxide signalling
Mike Seddon et al.
CARDIOVASCULAR RESEARCH (2007)
Myocardial function, energy provision, and carnitine deficiency in experimental uremia
Veena Reddy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Kim E. Jie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy
DJ Kennedy et al.
HYPERTENSION (2006)
Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury
CK Fujihara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat
A Erdely et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats
Hiroshi Kamijo et al.
NEPHRON PHYSIOLOGY (2006)
The severe cardiorenal syndrome: 'Guyton revisited'
LG Bongartz et al.
EUROPEAN HEART JOURNAL (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The cardiorenal syndrome: Lessons from the ADHERE database and treatment options
JT Heywood
HEART FAILURE REVIEWS (2004)
Protection of Wistar Furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase
A Erdely et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat
D Kennedy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Nitric oxide modulates vascular disease in the remnant kidney model
DH Kang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats
DM Attia et al.
KIDNEY INTERNATIONAL (2002)
Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition
AMG Verhagen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)